Plain-English translation of NCT07191171 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand why immunotherapy works well for some lung cancer patients but not others. This study will look back at medical records from patients who received immunotherapy to see if certain medications that change the bacteria in your gut may have affected how well the immunotherapy worked. The goal is to help doctors better predict which patients will benefit most from this treatment.
Only about 20–30% of lung cancer patients respond well to immunotherapy, even though it can be very effective. Scientists have discovered that the bacteria living in your intestines may play an important role in how well this treatment works. Some common medications can change these gut bacteria, so this research wants to find out if taking those medications around the same time as immunotherapy might affect how well the treatment helps patients.
You likely qualify if…
You likely don't qualify if…
This is a retrospective study, which means researchers will review your existing medical records rather than asking you to visit a clinic or take new medications. You would be agreeing to let the research team access your past medical information, including details about medications you took, your immunotherapy treatment, and how well it worked. There are no additional visits or procedures required beyond what you've already had as part of your regular cancer care.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
France